In addition, the reduced mRNA and protein expressions of MMP-12 in C6 rat glioma cells transfected with plasmids expressing MMP-12 shRNA have validated the in vitro efficiency of the designed, constructed, and synthesized MMP-12 shRNA expressing plasmids (Figure 4A). The gene discussed is MMP12; the disease is central nervous system cancer.